James E Flynn Insider Trading $ACRS Aclaris Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

James E Flynn in Aclaris Therapeutics, Inc.

Trading Symbol: ACRS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 964,101 shares
Current Value: $24,343,550
Latest Transaction: Jul 01 2019
$ACRS Market Capitalization: $537.94M
$ACRS Previous Close: $25.25

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of James E Flynn in Aclaris Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 01 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS2.69590,8011,589,6683,159,1653.7 M to 3.2 M (-15.75 %)
Jul 01 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS2.69108,674292,409964,1011.1 M to 964.1 K (-10.13 %)
Jun 26 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.501,3526,0863,749,9663.8 M to 3.7 M (-0.04 %)
Jun 26 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.503521,5851,072,7751.1 M to 1.1 M (-0.03 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5140,850184,1893,751,3183.8 M to 3.8 M (-1.08 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5110,63447,9481,073,1271.1 M to 1.1 M (-0.98 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5250,177226,9253,792,1683.8 M to 3.8 M (-1.31 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.5213,06359,0771,083,7611.1 M to 1.1 M (-1.19 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.62269,4021,243,3983,842,3454.1 M to 3.8 M (-6.55 %)
Jun 25 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS4.6270,135323,7011,096,8241.2 M to 1.1 M (-6.01 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.0571,869434,7501,166,9591.2 M to 1.2 M (-5.80 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.05108,696657,5244,111,7474.2 M to 4.1 M (-2.58 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.16172,8001,064,0161,238,8281.4 M to 1.2 M (-12.24 %)
May 13 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerSellS6.16261,3451,609,2324,220,4434.5 M to 4.2 M (-5.83 %)
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.93171
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.97171
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ7.00171
Jan 02 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ7.00171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.89171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.86171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.92171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.89171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.86171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.92171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.95171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.84171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.91171

Page:   1